CY2101B1 - Antitumor compositions and methods of treatment - Google Patents

Antitumor compositions and methods of treatment

Info

Publication number
CY2101B1
CY2101B1 CY9800043A CY9800043A CY2101B1 CY 2101 B1 CY2101 B1 CY 2101B1 CY 9800043 A CY9800043 A CY 9800043A CY 9800043 A CY9800043 A CY 9800043A CY 2101 B1 CY2101 B1 CY 2101B1
Authority
CY
Cyprus
Prior art keywords
treatment
methods
antitumor compositions
provides
antitumor
Prior art date
Application number
CY9800043A
Other languages
English (en)
Inventor
George Bernard Boder
William Joseph Ehlhardt
Gerald Burr Grindey
John Eldon Toth
John Frederick Worzalla
John Lyle Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY2101B1 publication Critical patent/CY2101B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY9800043A 1992-02-05 1998-10-19 Antitumor compositions and methods of treatment CY2101B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (1)

Publication Number Publication Date
CY2101B1 true CY2101B1 (en) 2002-04-05

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9800043A CY2101B1 (en) 1992-02-05 1998-10-19 Antitumor compositions and methods of treatment

Country Status (25)

Country Link
US (1) US5254582A (da)
EP (1) EP0555036B1 (da)
JP (1) JP3210117B2 (da)
KR (1) KR100246148B1 (da)
CN (1) CN1044239C (da)
AT (1) ATE170853T1 (da)
AU (1) AU658043B2 (da)
BR (1) BR9300469A (da)
CA (1) CA2088719A1 (da)
CY (1) CY2101B1 (da)
CZ (1) CZ282753B6 (da)
DE (1) DE69320844T2 (da)
DK (1) DK0555036T3 (da)
ES (1) ES2121940T3 (da)
FI (1) FI930453A (da)
HU (2) HU213231B (da)
IL (1) IL104574A (da)
MX (1) MX9300558A (da)
MY (1) MY109640A (da)
NO (1) NO302472B1 (da)
NZ (1) NZ245818A (da)
RU (1) RU2072996C1 (da)
SG (1) SG79181A1 (da)
YU (1) YU48915B (da)
ZA (1) ZA93689B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2263353C (en) * 1996-08-22 2002-04-23 Dong Wha Pharm. Ind. Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
AU4799797A (en) * 1996-10-04 1998-04-24 Eli Lilly And Company Antitumor compositions and methods of treatment
AU6967198A (en) * 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
DK1663978T3 (da) 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (da) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
IL69621A0 (en) * 1982-09-02 1983-12-30 Duphar Int Res Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
GR862353B (en) * 1985-09-23 1987-01-19 Lilly Co Eli Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
DK0555036T3 (da) 1999-06-07
EP0555036A3 (en) 1993-11-24
SG79181A1 (en) 2001-03-20
DE69320844T2 (de) 1999-03-04
AU658043B2 (en) 1995-03-30
IL104574A (en) 1997-02-18
KR100246148B1 (ko) 2000-04-01
US5254582A (en) 1993-10-19
HUT63842A (en) 1993-10-28
YU48915B (sh) 2002-11-15
NZ245818A (en) 1995-03-28
EP0555036B1 (en) 1998-09-09
CN1044239C (zh) 1999-07-21
CZ282753B6 (cs) 1997-09-17
FI930453A0 (fi) 1993-02-02
CN1075961A (zh) 1993-09-08
HU213231B (en) 1997-03-28
JP3210117B2 (ja) 2001-09-17
ZA93689B (en) 1994-08-01
ES2121940T3 (es) 1998-12-16
FI930453A (fi) 1993-08-06
NO302472B1 (no) 1998-03-09
DE69320844D1 (de) 1998-10-15
BR9300469A (pt) 1993-08-10
NO930380L (no) 1993-08-06
HU9300288D0 (en) 1993-04-28
MX9300558A (es) 1993-08-01
IL104574A0 (en) 1993-06-10
RU2072996C1 (ru) 1997-02-10
NO930380D0 (no) 1993-02-03
CZ12093A3 (en) 1993-12-15
MY109640A (en) 1997-03-31
YU5893A (sh) 1996-07-24
AU3218393A (en) 1993-08-12
HU211561A9 (en) 1995-12-28
EP0555036A2 (en) 1993-08-11
JPH05306277A (ja) 1993-11-19
CA2088719A1 (en) 1993-08-06
KR930017885A (ko) 1993-09-20
ATE170853T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
CY2413B1 (en) Protein kinase C inhibitors.
EP0555036A3 (en) Antitumor compositions and methods of treatment
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
CA2135710A1 (en) Melatonin derivatives for use in treating desynchronization disorders
MY118175A (en) Crystalline pharmaceutical product
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
GB9308111D0 (en) Active compound from a stonge
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
TH13149EX (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
IL100070A0 (en) Tetrahydroisoquinolinyl-carbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrol(2,3b)indole derivatives and pharmaceutical compositions containing the same